Covaxin

Covaxin (codenamed as BBV152) is an inactivated virus-based COVID-19 vaccine created by Bharat Biotech.

As of October 2021, 110.6 million people in India have received Covaxin.^[1] On 3 November 2021, the World Health Organization (WHO) approved the vaccine for emergency use.^[2]^[3]

Covaxin Media

A vial of Covaxin used at a private hospital in Bengaluru, India

References

↑ "Cowin statistics". Cowin. Ministry of health and family welfare India. 23 October 2021.
↑ "India's first homegrown COVID-19 shot wins WHO emergency use listing" (in en). Reuters. 3 November 2021. https://www.reuters.com/world/india/whos-advisory-group-recommends-emergency-listing-indias-first-homegrown-covid-19-2021-11-03/.
↑ "WHO issues emergency use listing for eighth COVID-19 vaccine". Press release. https://www.who.int/news/item/03-11-2021-who-issues-emergency-use-listing-for-eighth-covid-19-vaccine. Retrieved 3 November 2021.

This short article about medicine can be made longer. You can help Wikipedia by adding to it.

[1] "Cowin statistics". Cowin. Ministry of health and family welfare India. 23 October 2021.

[2] "India's first homegrown COVID-19 shot wins WHO emergency use listing" (in en). Reuters. 3 November 2021. https://www.reuters.com/world/india/whos-advisory-group-recommends-emergency-listing-indias-first-homegrown-covid-19-2021-11-03/.

[WHO_PR_20211103-3] "WHO issues emergency use listing for eighth COVID-19 vaccine". Press release. https://www.who.int/news/item/03-11-2021-who-issues-emergency-use-listing-for-eighth-covid-19-vaccine. Retrieved 3 November 2021.

[1]

[2]

[3]